Healthcare & Life Sciences

Rodin Therapeutics

series-a
series-a
Stage
1
Investors

About

Rodin Therapeutics is a biotechnology company focused on developing novel therapeutics to restore cognitive function by targeting mechanisms underlying memory loss and neurodegenerative diseases.

Explore Rodin Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.